CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tetragenetics announced today that it has received Phase II funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables individuals worldwide to test bold ideas to address persistent health and development challenges. Dr. Ted Clark will continue to pursue an innovative global health research project, titled “A Highly Potent Delivery System for Malaria Vaccine Antigens.”
